The following is an abstract from the Harm Reduction Journal. The title is Prescribing Cannabis for Harm Reduction.
“Neuropathic pain affects between 5% and 10% of the US population and can be refractory to treatment. Opioids may be recommended as a second-line pharmacotherapy but have risks including overdose and death. Cannabis has been shown to be effective for treating nerve pain without the risk of fatal poisoning. The author suggests that physicians who treat neuropathic pain with opioids should evaluate their patients for a trial of cannabis and prescribe it when appropriate prior to using opioids. This harm reduction strategy may reduce the morbidity and mortality rates associated with prescription pain medications.”
If you click here you can go to the source with a link to the complete commentary. Yes, commentary. Something else that struck me was no letters after the author’s name. Obviously the individual isn’t a doc.
So who is this Mark Collen guy? Why are his comments published in a peer-reviewed article? I think I’ve found the connection. Take a look at this project:
I’m tempted to drag out the old pencils and pad.